Small implantable devices “Bioelectronic Medicines” implanted on nerves leading to organs will be used to treat a variety of diseases, especially in the field of chronic autoimmune diseases.
Compared to the pace of innovation in electronic consumer products, the pace of innovation in electronic medical devices is lagging behind. It is the overarching objective of Moore4Medical to accelerate innovation in electronic medical devices. Moore4Medical will:
- Address emerging medical domains
The convergence between the Pharmaceutical, MedTech and ECS industries, is resulting in new exciting new opportunities for industry and society that will help managing the cost of healthcare.